PVLA
PALVELLA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$150.56
−2.44%0
Insider buys (3m)
22
Insider sells (3m)
-$6.2M
Net value (3m)
+27.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 18, 2026 | Goin Kathleen · officer: Chief Operating Officer | M-Exempt | 2,154 | $7.14 |
| Sep 18, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 1,654 | $153 |
| Sep 18, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 989 | $152 |
| Sep 18, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 1,659 | $151 |
| Sep 18, 2026 | Goin Kathleen · officer: Chief Operating Officer | M-Exempt | 2,148 | $9.08 |
| Sep 15, 2026 | JENKINS GEORGE M · director | Sale | 6,160 | $152 |
| Sep 15, 2026 | JENKINS GEORGE M · director | Sale | 5,632 | $151 |
| Sep 15, 2026 | JENKINS GEORGE M · director | Sale | 1,274 | $153 |
| Sep 15, 2026 | JENKINS GEORGE M · director | Sale | 4,577 | $152 |
| Sep 15, 2026 | JENKINS GEORGE M · director | Sale | 6,520 | $151 |
| Sep 15, 2026 | JENKINS GEORGE M · director | Sale | 1,560 | $153 |
| Sep 15, 2026 | JENKINS GEORGE M · director | Sale | 954 | $149 |
| Sep 15, 2026 | JENKINS GEORGE M · director | Sale | 263 | $150 |
| Sep 15, 2026 | JENKINS GEORGE M · director | Sale | 560 | $151 |
| Sep 4, 2026 | KIRITSY CHRISTOPHER P · director | Sale | 313 | $157 |
| Sep 4, 2026 | KIRITSY CHRISTOPHER P · director | M-Exempt | 313 | $127 |
| Aug 20, 2026 | Goin Kathleen · officer: Chief Operating Officer | M-Exempt | 2,148 | $9.08 |
| Aug 20, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 302 | $157 |
| Aug 20, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 102 | $156 |
| Aug 20, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 400 | $153 |
| Aug 20, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 1,998 | $152 |
| Aug 20, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 1,500 | $151 |
| Aug 20, 2026 | Goin Kathleen · officer: Chief Operating Officer | M-Exempt | 2,154 | $7.14 |
| Jul 17, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 522 | $147 |
| Jul 17, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 1,911 | $150 |
| Jul 17, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 1,029 | $149 |
| Jul 17, 2026 | Goin Kathleen · officer: Chief Operating Officer | Sale | 840 | $148 |
| Jul 17, 2026 | Goin Kathleen · officer: Chief Operating Officer | M-Exempt | 2,148 | $9.08 |
| Jul 17, 2026 | Goin Kathleen · officer: Chief Operating Officer | M-Exempt | 2,154 | $7.14 |
| Jul 1, 2026 | Pauls Matthew · director | A-Award | 6,000 | $155 |
Institutional positioning
13F filings over the trailing two quarters
New 105Increased 156Reduced 75Sold out 19
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 1,153,496 | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Reduced | 1,135,406 | Aug 14, 2026 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | Increased | 980,758 | May 15, 2026 |
| BVF INC/IL | Increased | 960,989 | May 15, 2026 |
| JENNISON ASSOCIATES LLC | Increased | 960,619 | Aug 3, 2026 |
| BlackRock, Inc. | Increased | 918,357 | Aug 7, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Increased | 882,400 | May 15, 2026 |
| Frazier Life Sciences Management, L.P. | Unchanged | 882,400 | Aug 14, 2026 |
| First Light Asset Management, LLC | Reduced | 771,901 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 686,853 | May 13, 2026 |
| BVF INC/IL | Reduced | 672,789 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 653,172 | Aug 7, 2026 |
| JENNISON ASSOCIATES LLC | Increased | 640,611 | May 6, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 638,868 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 513,794 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 18, 2026